Skip to main content

Table 1 The British VLAs Socio-demographic Characteristics of Participants [Phase 2 – T1]

From: The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK

 

AS (n = 165)

OA (n = 184)

SLE (n = 164)

SS (n = 170)

CP/FM (n = 194)

CH/UL (n = 158)

PSS (n = 171)

RA (n = 340)

Response Rate (%)

79

80

89

88

77

73

88

80

Age (Mean (SD))

53.48 (13.89)

63.28 (10.41)

53.20 (13.22)

65.52 (10.65)

53.10 (13.47)

54.66 (14.13)

62.88 (11.25)

61.96 (12.09)

Gender (M: F)

118:45

41:143

7:157

12:158

24:170

48:109

10:160

89:251

Recruited from:

NHS: Patient Organisation

120:45

184:0

40:124

38:132

88:106

122:36

104:67

 

Condition duration in years (Mean (SD):

24.75 (15.16)

10.43 (10.24)

18.22 (11.54)

16.67 (11.15)

12.96 11.62)

6.0 (12.34)

16.44 (17.04)

14.44 (11.73)

Marital status: n (%):

 Single/Divorced/Widowed

38 (33%)

46 (25%)

31 (19%)

58 (34%)

58 (30%)

42 (26%)

54 (32%)

94 (28%)

 Married/Living with partner

126 (77%)

136 (74%)

133 (81%)

111 (66%)

136 (70%)

115 (74%)

117 (68%)

241 (71%)

 Missing

1 (0.0%)

2 (0.0%)

0

1 (0.0%)

0

1 (0.0%)

0

5 (1%)

Living status: n (%)

 Alone

26 (16%)

43 (23%)

17 (10%)

52 (30%)

38(20%)

36 (24%)

47 (28%)

70 (21%)

 Family/Significant other

134 (81%)

133 (73%)

143 (87%)

115 (68%)

145 (75%)

113 (71%)

121 (71%)

245 (72%)

 Missing

5 (3%)

8 (4%)

9 (3%)

3 (2%)

11 (5%)

8 (5%)

3 (1%)

25 (7%)

Children living at home n (%):

41 (25%)

12 (7%)

28 (17%)

3 (2%)

47 (24%)

24 (15%)

17 (10%)

36 (10.5)

Employment status:

 Paid employment

87 (53%)

56 (30%)

62 (38%)

38 (22%)

70 (36%)

80 (51%)

64 (38%)

108 (32%)

 Long term sick leave

7 (4%)

5 (3%)

9 (6%)

2 (1%)

14 (7%)

10 (6%)

2 (1%)

9 (2%)

 Early retired ill-health

19 (12%)

13 (7%)

31 (19%)

29 (17%)

30 (16%)

10 (6%)

16 (10%)

35 (10%)

 Unemployed

5 (3%)

3 (2%)

1 (1%)

1 (1%)

16 (8%)

4 (3%)

2 (1%)

4 (1%)

 Retired

41 (25%)

103 (57%)

44 (26%)

95 (56%)

38 (26%)

44 (28%)

82 (48%)

169 (50%)

 Homemaker

5 (3%)

2 (1%)

14 (9%)

4 (2%)

21 (11%)

6 (4%)

3 (2%)

8 (2%)

 Student

0

0

2 (1%)

0

3 (1%)

1 (0.0%)

0

1 (0.0%)

 Missing

1 (0.0%)

2 (0.0%)

1 (0.0%)

1 (0.0%)

2 (0.0%)

3 (0.0%)

1 (0.0%)

5 (1%)

Education level (ISCED):

 Level 1: Compulsory school

19 (12%)

47 (25%)

16 (10%)

23 (13%)

20 (10%)

23 (15%)

22 (13%)

78 (23%)

 Level 2: Secondary 1st stage

22 (14%)

43 (23%)

40 (24%)

37 (22%)

45 (23%)

22 (14%)

39 (23%)

82 (24%)

 Level 3: Secondary second

15 (9%)

7 (4%)

20 (12%)

20 (12%)

14 (7%)

16 (10%)

14 (8%)

22 (6%)

 Level 4: Post-secondary

37 (22%)

23 (13%)

18 (11%)

18 (10%)

26 (14%)

19 (12%)

28 (16%)

51 (15%)

 Level 5: Tertiary

63 (38%)

46 (25%)

69 (42%)

66 (39%)

81 (42%)

69 (44%)

62 (36%)

90 (26%)

 Other

2 (1%)

0

0

0

0

0

0

0

 Missing

7 (4%)

18 (10%)

1 (1%)

6 (4%)

8 (4%)

8 (5%)

6 (4%)

17 (5%)

Current medication:

 Not on DMARDs

89 (54%)

n/a

56 (34%)

143 (84%)

n/a

n/a

113 (66%)

 

 Monotherapy

11 (7%)

 

76 (46%)

25 (15%)

  

52 (31%)

 

 Combination therapy

0

 

29 (18%)

2 (1%)

  

2 (1%)

 

 Biologic drugs

65 (39%)

 

3 (2%)

0

  

2 (1%)

 

 Missing

0

 

0

0

  

2 (1%)

 
  1. Key: AS Ankylosing spondylitis; OA Osteoarthritis; SLE Systemic Lupus Erythematosus; SS Systemic Sclerosis; CP/FM Chronic Pain/ Fibromyalgia;
  2. CHUL chronic hand/upper limb conditions; PSS Primary Sjorgens Syndrome; RA Rheumatoid Arthritis; ISCED International Standard Classification of Education; DMARDs Disease Modifying Anti-Rheumatic Drugs